利格列汀雜質(zhì) 全套對(duì)照品

時(shí)間：2020/5/6閱讀：1278

利格列汀雜質(zhì) 全套對(duì)照品

深圳艾利蒙生物科技有限公司可提供利格列汀雜質(zhì)全套，并隨貨提供COA證書，HPLC，NMR，MS圖譜，10mg/25mg/50mg/100mg等多種規(guī)格可選。

部分雜質(zhì)長期備有現(xiàn)貨，可快速發(fā)貨，并可根據(jù)客戶需要提供雜質(zhì)定制服務(wù)。

利格列汀的相關(guān)介紹：

中文名稱：利格列汀

中文別名：8-[(3R)-3-氨基-1-哌啶基]-7-(2-丁炔基)-3,7-二氫-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮；利拉利汀;

英文名稱：linagliptin

英文別名：Trajenta；BI-1356-BS；Ondero；BI-1356；Linagliptin；Tradjenta；8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione;

CAS號(hào)：668270-12-0

分子式：C25H28N8O2

分子量：472.23400

結(jié)構(gòu)式：

適應(yīng)癥：

利格列汀與二甲雙胍和磺脲類藥物聯(lián)合使用，配合飲食控制和運(yùn)動(dòng)，可用于成年2型糖尿病患者的血糖控制。

利格列汀雜質(zhì) 全套對(duì)照品

利格列汀雜質(zhì)為我司優(yōu)勢(shì)雜質(zhì)，長期備有庫存，發(fā)貨快。雜質(zhì)結(jié)構(gòu)式及更多其他雜質(zhì)對(duì)照品，可進(jìn)入我公司展臺(tái)詳細(xì)查看。

附：利格列汀雜質(zhì)列表：

中文名稱	英文名稱
利格列汀標(biāo)準(zhǔn)品	Linagliptin
利格列汀雜質(zhì)1	7-(but-2-yn-1-yl)-8-((2-hydroxyethyl)amino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)2	2-((R)-3-aminopiperidine-1-carbonyl)-N-((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)benzamide
利格列汀雜質(zhì)3	N-Phthalimide-linagliptin
利格列汀雜質(zhì)4	Linagliptin Impurity S
利格列汀雜質(zhì)5	N1,N2-bis((R)-1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)phthalamide
利格列汀雜質(zhì)6	(R)-2-((1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamoyl)benzoic acid
利格列汀雜質(zhì)7	Linagliptin Diene Impurity
利格列汀雜質(zhì)8	Linagliptin Acetamide
利格列汀雜質(zhì)9	8-bromo-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)10	(R)-tert-butyl (1-(1,7-di(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
利格列汀雜質(zhì)11	(R)-8-(3-aminopiperidin-1-yl)-1,7-di(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)12	8-bromo-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)13	(R)-tert-butyl (1-(3-methyl-7-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
利格列汀雜質(zhì)14	(R)-8-(3-aminopiperidin-1-yl)-3-methyl-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)15	(R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)16	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)-2,2,2-trifluoroacetamide
利格列汀雜質(zhì)17	(S)-Linagliptin
利格列汀雜質(zhì)18	7-(but-2-yn-1-yl)-8-(dimethylamino)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)19	N-(2-acetylphenyl)-2-(8-bromo-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
利格列汀雜質(zhì)20	(R)-tert-butyl (1-(1-(2-((2-acetylphenyl)amino)-2-oxoethyl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
利格列汀雜質(zhì)21	(R)-N-(2-acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide
利格列汀雜質(zhì)22	(R)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
利格列汀雜質(zhì)23	(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)24	(S)-tert-butyl (1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
利格列汀雜質(zhì)25	(R)-7-(but-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)26	(R)-N-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)formamide
利格列汀雜質(zhì)27	8-bromo-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)28	(R)-8-(3-aminopiperidin-1-yl)-7-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
利格列汀雜質(zhì)29	(R)-1-((4-methylquinazolin-2-yl)methyl)piperidin-3-amine

深圳艾利蒙生物科技有限公司主營醫(yī)藥標(biāo)準(zhǔn)品及雜質(zhì)對(duì)照品，所有雜質(zhì)均提供HPLC，NMR，MS圖譜及CoA證：舒更葡糖鈉雜質(zhì)，骨化三醇雜質(zhì)，阿法骨化醇雜質(zhì)，艾地骨化醇雜質(zhì)，西格列汀雜質(zhì)，利伐沙班雜質(zhì)，依托考昔雜質(zhì)，左氧氟沙星雜質(zhì)，阿加曲班雜質(zhì)，利奈唑胺雜質(zhì)，匹伐他汀雜質(zhì)，利格列汀雜質(zhì)，替格瑞洛雜質(zhì)，阿哌沙班雜質(zhì)，西他沙星雜質(zhì)，伊馬替尼雜質(zhì)，洛索洛芬鈉雜質(zhì)，普瑞巴林雜質(zhì)，環(huán)苯扎林雜質(zhì)，鹽酸帕洛諾司瓊雜質(zhì)等。

人妻精品久久久久中文字幕青草,亚洲天堂东京热AV,少妇人妻久久无码专区,亚洲无码国产精选

利格列汀雜質(zhì) 全套對(duì)照品

會(huì)員登錄

收藏該商鋪

提示